Nutex Health Inc.
NUTX
$124.93
$4.163.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 141.25% | 93.80% | 26.02% | 39.80% | 31.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 141.25% | 93.80% | 26.02% | 39.80% | 31.69% |
| Cost of Revenue | 49.31% | 35.56% | 4.31% | 5.48% | 1.82% |
| Gross Profit | 460.45% | 311.02% | 150.48% | 2,104.00% | 7,176.84% |
| SG&A Expenses | 168.86% | 62.36% | 37.00% | 27.84% | 58.66% |
| Depreciation & Amortization | 11.77% | 7.85% | 13.56% | 15.11% | 20.75% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.46% | 37.48% | 8.88% | 8.78% | 8.46% |
| Operating Income | 4,652.64% | 10,762.48% | 347.46% | 140.86% | 111.53% |
| Income Before Tax | 523.09% | 326.33% | -10.90% | 92.98% | 90.98% |
| Income Tax Expenses | 966.27% | 385.70% | 1,189.52% | 75.70% | -131.38% |
| Earnings from Continuing Operations | 478.03% | 319.40% | -22.89% | 93.31% | 92.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1,740.09% | -1,723.74% | -242.20% | -188.36% | -130.19% |
| Net Income | 263.83% | 213.96% | -42.23% | 91.30% | 90.92% |
| EBIT | 4,652.64% | 10,762.48% | 347.46% | 140.86% | 111.53% |
| EBITDA | 913.33% | 861.20% | 939.75% | 207.26% | 181.48% |
| EPS Basic | 231.87% | 192.80% | -50.40% | 91.12% | 90.74% |
| Normalized Basic EPS | 407.21% | 283.23% | 77.73% | 77.54% | 38.31% |
| EPS Diluted | 223.32% | 185.95% | -44.35% | 91.13% | 90.75% |
| Normalized Diluted EPS | 389.13% | 272.40% | 77.73% | 77.54% | 38.31% |
| Average Basic Shares Outstanding | 16.37% | 15.94% | 5.91% | 2.80% | -0.12% |
| Average Diluted Shares Outstanding | 20.11% | 17.86% | 5.91% | 2.80% | -0.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 3.76% | 1.16% | 0.87% | -1.06% | -0.09% |